The absence of CDKN1C (p57KIP2) promoter methylation in myeloid malignancies also characterizes plasma cell neoplasms.
Hatzimichael
Eleftheria
E
Dasoula
Aggeliki
A
Benetatos
Leonidas
L
Makis
Alexandros
A
Stebbing
Justin
J
Crook
Tim
T
Syrrou
Maria
M
Bourantas
Konstantinos L
KL
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D050761:Cyclin-Dependent Kinase Inhibitor p57 / Q000235:genetics*; D019175:DNA Methylation; D004273:DNA, Neoplasm / Q000235:genetics; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000235:genetics; D054219:Neoplasms, Plasma Cell / Q000235:genetics*
C493964:CDKN1C protein, human; D050761:Cyclin-Dependent Kinase Inhibitor p57; D004273:DNA, Neoplasm